Connect with Lyme



Why Congress Must Enact Medical Insurance Coverage Laws for Lyme Disease

This article provides an overview of Lyme disease and its prevalence in the United States. Despite scientific evidence showing the infection can persist long after initial treatment, most insurance companies restrict access to treatment beyond twenty-eight days, leaving patients to bear much of the financial burden. Barrett argues that the existing approach to addressing Lyme disease is insufficient; therefore, Congress must enact legislation to change this.